<sentence id="0">Site-specific N-glycan characterization of human complement factor H.</sentence>
<sentence id="1">Human complement factor H ( CFH ) is a plasma glycoprotein involved in the regulation of the alternative pathway of the complement system .</sentence>
<sentence id="2">A deficiency in CFH is a cause of severe pathologies like atypical haemolytic uraemic syndrome ( aHUS ) .</sentence>
<sentence id="3">CFH is a 155-kDa glycoprotein containing nine <scope type="spec" id="0"> <cue type="spec" id="0">potential</cue> N-glycosylation sites</scope> .</sentence>
<sentence id="4">In the current study , we present a quantitative glycosylation analysis of CFH using capillary electrophoresis and a complete site-specific N-glycan characterization using matrix-assisted laser desorption/ionization time-of-flight ( MALDI-TOF ) and liquid chromatography-electrospray ionization tandem mass spectrometry ( LC-ESIMS/MS ) .</sentence>
<sentence id="5">A 17.9-kDa mass decrease , observed after glycosidase treatment , <scope type="spec" id="1"> <cue type="spec" id="1">indicated that</cue> N-glycosylation is the major post-translational modification of CFH</scope> .</sentence>
<sentence id="6">This mass difference is consistent with CFH glycosylation by diantennary disialylated glycans of 2204 Da on eight sites .</sentence>
<sentence id="7">CFH was <scope type="neg" id="2"><cue type="neg" id="2">not</cue> sensitive to endoglycosidase H ( Endo H ) deglycosylation</scope> , <scope type="spec" id="3"> <cue type="spec" id="3">indicating</cue> the absence of hybrid and oligomannose structures</scope> .</sentence>
<sentence id="8">Quantitative analysis showed that CFH is mainly glycosylated by complex , diantennary disialylated , non-fucosylated glycans .</sentence>
<sentence id="9">Disialylated fucosylated and monosialylated non-fucosylated oligosaccharides were also identified .</sentence>
<sentence id="10">MS analysis allowed complete characterization of the protein backbone , verification of the glycosylation sites and site-specific N-glycan identification .</sentence>
<sentence id="11">The <scope type="neg" id="4"><cue type="neg" id="4">absence</cue> of glycosylation at Asn199 of the NGSP sequence of CFH</scope> is shown .</sentence>
<sentence id="12">Asn511 , Asn700 , Asn784 , Asn804 , Asn864 , Asn893 , Asn1011 and Asn1077 are glycosylated essentially by diantennary disialylated structures with a relative distribution varying between 45 % for Asn804 and 75 % for Asn864 .</sentence>
<sentence id="13">Diantennary monosialylated glycans and triantennary trisialylated fucosylated and non-fucosylated structures have also been identified .</sentence>
<sentence id="14">Interestingly , the sialylation level along with the amount of triantennary structures decreases from the N- to the C-terminal side of the protein .</sentence>